We speculate that this is not because of the higher frequency of HNF4α-positive cases in Caucasians, but because of the higher frequency of KRAS mutations in HNF4α-negative adenocarcinomas (mainly TRU-type lung adenocarcinomas) in Caucasians. The gene discussed is KRAS; the disease is adenocarcinoma.